Cargando…
Proteomic Study to Survey the CIGB-552 Antitumor Effect
CIGB-552 is a cell-penetrating peptide that exerts in vitro and in vivo antitumor effect on cancer cells. In the present work, the mechanism involved in such anticancer activity was studied using chemical proteomics and expression-based proteomics in culture cancer cell lines. CIGB-552 interacts wit...
Autores principales: | Rodríguez-Ulloa, Arielis, Gil, Jeovanis, Ramos, Yassel, Hernández-Álvarez, Lilian, Flores, Lisandra, Oliva, Brizaida, García, Dayana, Sánchez-Puente, Aniel, Musacchio-Lasa, Alexis, Fernández-de-Cossio, Jorge, Padrón, Gabriel, González López, Luis J., Besada, Vladimir, Guerra-Vallespí, Maribel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630370/ https://www.ncbi.nlm.nih.gov/pubmed/26576414 http://dx.doi.org/10.1155/2015/124082 |
Ejemplares similares
-
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
por: Núñez de Villavicencio-Díaz, Teresa, et al.
Publicado: (2015) -
The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
por: Fernández Massó, Julio R., et al.
Publicado: (2013) -
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020) -
Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
por: Astrada, Soledad, et al.
Publicado: (2018) -
CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition
por: Rosales, Mauro, et al.
Publicado: (2022)